Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 6, 1999

View Archived Issues

New cardioselective K(ATP) channel blocker inhibits ventricular fibrillation in ischemic rat model

Company Profile: Switch Biotech

Ciba Vision licenses Destiny's photodynamic therapy technology

Schering-Plough to manufacture Ampligen for HemispheRx

Alliance reports progress in phase III Oxygent trials

Pokeweed antiviral protein shows potential in AIDS

King Pharmaceuticals to acquire Medco

Abgenix enters human antibody drug collaboration with Human Genome Sciences

Pfizer presents novel hygromycin derivatives with antibacterial/antiprotozoal properties

p38 MAP kinase inhibitors described by Roche for inflammatory disorders

New series from Pfizer enhances serotonergic neurotransmission

Novel neuroprotective nitrate compound is the cornerstone of GoBang Therapeutics' pipeline

Hypoglycemics that enhance insulin sensitivity under study at SSP, presented at chemistry meeting

Novel anticonvulsants are associated with less toxicity

Cerebrus acquisition solidifies, enhances Vanguard Medica's R&D pipeline

Kyorin discusses design of anti-MRSA cephalosporins with affinity for PBP2'

MetaPhore awarded grants for research on metal-related therapeutics

Phase III Zomaril trial yields encouraging preliminary results

Promising treatment for Parkinson's disease in development at Juvantia

ImClone and Merck KGaA initiate first international phase III trial center of C225

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...